ABSTRACT Objective People with HIV (PWH) on antiretroviral therapy (ART) still experience neurocognitive dysfunction and accelerated brain volume loss. To assess whether the serotonergic and dopaminergic systems are affected, we used [11C]DASB positron emission tomography (PET) to assess presynaptic serotonergic function and [18F]FDOPA PET to measure ...
Chuen‐Yen Lau+12 more
wiley +1 more source
Are We There Yet? Co-Production in Recovery Colleges. [PDF]
Jones K, Crawford G, Jancey J.
europepmc +1 more source
The Politics of Vaccination: A Global History
Laura E. Power
doaj +1 more source
On the influence of the temperature of liquid hydrogen on the germinative power of seeds
W. T. Thiselton-Dyer
openalex +2 more sources
Some Extensions to Multiple Series of Abel's Theorem on the Continuity of Power Series [PDF]
T. J. I’A. Bromwich, G. H. Hardy
openalex +1 more source
Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases
ABSTRACT Objective Approximately half of patients with hereditary myopathies remain without a definitive genetic diagnosis after DNA next‐generation sequencing (NGS). Here, we implemented transcriptome analysis of muscle biopsies as a complementary diagnostic tool for patients with muscle disease but no definitive genetic diagnosis after exome ...
Alba Segarra‐Casas+24 more
wiley +1 more source
AIMP-Based Power Allocation for Radar Network Tracking Under Countermeasures Environment. [PDF]
Xing X, Xu L, Nie L, Li X.
europepmc +1 more source
IV. On the power of penetrating into space by telescopes; with a comparative determination of the extent of that power in natural vision, and in telescopes of various sizes and constructions; illustrated by select observations [PDF]
William Herschel
openalex +1 more source
An Analysis for IDH‐Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice
ABSTRACT Purpose There is ongoing debate regarding the therapeutic approach and prognosis for IDH‐mutant grade 4 astrocytoma, a newly defined subtype of diffuse glioma in the 2021 WHO classification system for central nervous system tumors (WHO CNS 5). The aim of this study was to explore the clinical outcome and prognosticators for newly diagnosed IDH‐
Xianxin Qiu+13 more
wiley +1 more source